Skin cancers, translational research, drug development, cutaneous immunology and immunotherapy
We have intensively studied the immune biology of cutaneous lymphomas, cutaneous melanoma and epithelial skin cancers. Based on the microenvironment of these tumors, we have established immune interventions in cell cultures and animal models. Translational research applies this new knowledge to our patients in order to provide effective treatment with best quality of life.
Professor Dummer’s principal research interests are molecular biology, immunology and immunotherapy of cutaneous malignancies, including cutaneous lymphomas and melanomas. He has published more than 677 papers with a cumulative impact factor of more than 5787. He was past-president of the Melanoma Project Group of the Swiss Institute for Applied Cancer Research from 1999 -2016, is a member of German National Academy of Sciences (Leopoldina) and is past board member of the Society for Melanoma Research and past President of the International Society for Cutaneous Lymphomas. He is a founding and board member of the European Association of Dermato-Oncology (EADO), ESMO, EATI, URPP and past President of the European Society for Dermatological Research (ESDR). In the last 20 years, he has developed a leading skin cancer center in Zurich. This center offers best medical care and a network of clinical trials reaching from phase I to phase III. Towards research translation, he has established numerous cooperations with basic research groups at the UZH and federal University (ETH). This has resulted in improving the understanding of cutaneous malignancies.Publications